JFS Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

JFS Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.4K	Hold	778	–	–	﹤0.01%	697
2026 Q1	$23.4K	Sell	778 -2,000	-72%	-$64.3K	﹤0.01%	698
2025 Q4	$86.7K	Hold	2,778	–	–	﹤0.01%	433
2025 Q3	$56.1K	Buy	2,778 +2,000	+257%	+$35.1K	﹤0.01%	487
2025 Q2	$13K	Sell	778 -16	-2%	-$258	﹤0.01%	783
2025 Q1	$12.2K	Sell	794 -411	-34%	-$7.34K	﹤0.01%	813
2024 Q4	$26.6K	Buy	1,205 +141	+13%	+$2.56K	﹤0.01%	584
2024 Q3	$19.2K	Buy	1,064 +253	+31%	+$4.43K	﹤0.01%	655
2024 Q2	$13.2K	Buy	811 +33	+4%	+$508	﹤0.01%	711
2024 Q1	$11K	Buy	778 +65	+9%	+$819	﹤0.01%	786
2023 Q4	$7.44K	Sell	713 -50	-7%	-$467	﹤0.01%	892
2023 Q3	$7.78K	Buy	763 +266	+54%	+$2.48K	﹤0.01%	814
2023 Q2	$3.74K	Sell	497 -241	-33%	-$1.95K	﹤0.01%	1134
2023 Q1	$6.53K	Hold	738	–	–	﹤0.01%	888
2022 Q4	$6.73K	Sell	738 -240	-25%	-$2.09K	﹤0.01%	868
2022 Q3	$8K	Buy	978 +413	+73%	+$3.65K	﹤0.01%	827
2022 Q2	$4K	Sell	565 -150	-21%	-$1.31K	﹤0.01%	1120
2022 Q1	$7K	Buy	715 +380	+113%	+$3.17K	﹤0.01%	936
2021 Q4	$3K	Buy	335 +150	+81%	+$1.35K	﹤0.01%	994
2021 Q3	$2K	Hold	185	–	–	﹤0.01%	785
2021 Q2	$2K	Hold	185	–	–	﹤0.01%	555
2021 Q1	$2K	Hold	185	–	–	﹤0.01%	553
2020 Q4	$2K	Hold	185	–	–	﹤0.01%	540
2020 Q3	$2K	Hold	185	–	–	﹤0.01%	520
2020 Q2	$2K	Hold	185	–	–	﹤0.01%	498
2020 Q1	$2K	Hold	185	–	–	﹤0.01%	451
2019 Q4	$2K	Hold	185	–	–	﹤0.01%	464
2019 Q3	$1K	Hold	185	–	–	﹤0.01%	498
2019 Q2	$2K	Hold	185	–	–	﹤0.01%	438
2019 Q1	$3K	Hold	185	–	–	﹤0.01%	427
2018 Q4	$3K	Hold	185	–	–	﹤0.01%	413
2018 Q3	$4K	Hold	185	–	–	﹤0.01%	471
2018 Q2	$4K	Hold	185	–	–	﹤0.01%	416
2018 Q1	$3K	Hold	185	–	–	﹤0.01%	463
2017 Q4	$4K	Buy	185 +1	+0.5%	+$15	﹤0.01%	447
2017 Q3	$3K	Buy	184 +1	+0.5%	+$23	﹤0.01%	412
2017 Q2	$6K	Buy	183 +3	+2%	+$93	﹤0.01%	367
2017 Q1	$7K	Hold	180	–	–	﹤0.01%	372
2016 Q4	$7K	Sell	180 -2,315	-93%	-$92.4K	﹤0.01%	372
2016 Q3	$115K	Buy	2,495 +1,451	+139%	+$75.7K	0.03%	170
2016 Q2	$52K	Sell	1,044 -36	-3%	-$1.92K	0.01%	251
2016 Q1	$58K	Buy	1,080 +38	+4%	+$2.23K	0.02%	221
2015 Q4	$68K	Buy	1,042 +1	+0.1%	+$62	0.02%	219
2015 Q3	$59K	Buy	1,041 +175	+20%	+$11.3K	0.03%	199
2015 Q2	$51K	Hold	866	–	–	0.03%	182
2015 Q1	$54K	Hold	866	–	–	0.03%	177
2014 Q4	$50K	Hold	866	–	–	0.01%	188
2014 Q3	$47K	Hold	866	–	–	0.01%	185
2014 Q2	$45K	Buy	+866	New	+$44.3K	0.01%	198
2013 Q4	–	Sell	-12,466	Closed	-$471K	–	139
2013 Q3	$471K	Buy	12,466 +2,509	+25%	+$97.9K	0.22%	66
2013 Q2	$390K	Buy	+9,957	New	+$388K	0.2%	67

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

JFS Wealth Advisors's TEVA Position: Q2 2026 in Review

JFS Wealth Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 778 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

JFS Wealth Advisors first reported a position in TEVA in Q2 2013 and has held it in 51 quarters since. The position peaked at $471K in Q3 2013. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

JFS Wealth Advisors held 778 shares of Teva Pharmaceuticals worth $26.4K as of Q2 2026.
JFS Wealth Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #697 holding.
JFS Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
JFS Wealth Advisors's Teva Pharmaceuticals position peaked at $471K in Q3 2013.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.